🔎 Trials Near Me

Akèy › Kansè Poumon ki pa ti selil › Wisconsin › Green Bay

Etid klinik pou Kansè Poumon ki pa ti selil nan Green Bay, WI

14 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Green Bay (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Ap rekriteFaz 3
  • Bellin Memorial Hospital, Green Bay
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ap rekriteFaz 3
  • Bellin Memorial Hospital, Green Bay
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
  • ak 4 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Ap rekriteFaz 3
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06498635

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Ap rekriteFaz 3
  • HSHS St. Vincent Hospital Regional Cancer Center, Green Bay
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07361510

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Ap rekriteFaz 2
  • Aurora BayCare Medical Center, Green Bay
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT03191149

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • ThedaCare Regional Cancer Center, Appleton · 26 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Aurora BayCare Medical Center, Green Bay
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Aurora BayCare Medical Center, Green Bay
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Ap rekriteFaz 2/3
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
  • Aurora BayCare Medical Center, Green Bay
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
  • Aurora BayCare Medical Center, Green Bay
  • ak 3 plis
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Ap rekriteEtid obsèvasyon
  • ThedaCare Regional Cancer Center, Appleton · 26 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114

Etid Kansè Poumon ki pa ti selil nan lòt vil

Lòt etid nan Green Bay

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.